Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection [Phase 3]
A Phase 3 trial of a fixed-dose combination of Sofosbuvir/Velpatasvir for 12 weeks in adults with chronic hepatitis C virus infection has co…
-
CLINICAL_TRIALS research · 2019-03-15Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C
Real world evidence study evaluating the effectiveness of paritaprevir/ritonavir-ombitasvir, with or without dasabuvir and ribavirin, in par…
-
CLINICAL_TRIALS research · 2019-03-14Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation
Real-world evidence study assessing the effectiveness of paritaprevir/ritonavir-ombitasvir + dasabuvir without ribavirin in chronic hepatiti…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C
Observational study assessing dual and triple therapies based on Pegasys (peginterferon alfa-2a) in chronic hepatitis C; study completed wit…
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment [Phase 3]
Phase 3 trial evaluating Glecaprevir/pibrentasvir in adults with chronic HCV genotype 1-6 infection and renal impairment has completed with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use [Phase 2]
Phase II trial update evaluating sofobuvir and GS-5816 for chronic hepatitis C in people with recent injection drug use; study completed.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis [Phase 3]
Phase 3 trial update evaluating sofobuvir/velpatasvir with or without ribavirin for 12 weeks in adults with chronic HCV and decompensated ci…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal Clinic
Clinical trial update indicating the study evaluating Hepatitis C screening during pregnancy at an inner-city Toronto prenatal clinic has co…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus [Phase 3]
A Phase 3 trial evaluating sofosbuvir and daclatasvir for hepatitis C in 200 patients co-infected with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients [Phase 3]
Phase 3 trial evaluating the efficacy of grazoprevir/elbasvir in early chronic hepatitis C among HIV/HCV co-infected patients.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection [Phase 3]
Phase 3 clinical trial completed evaluating ABT-493/ABT-530 in Japanese adults with genotype 2 chronic hepatitis C virus infection; results …
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients [Phase 4]
Phase 4 trial evaluating Sofosbuvir and Daclatasvir in 1000 Hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Study of Combination Treatment With IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 Patients [Phase 1]
Phase 1 study evaluating the safety and preliminary efficacy of combining IMO-2125 with ribavirin in treatment-naïve genotype 1 hepatitis C …
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients [Phase 1]
Phase 1, placebo-controlled, dose-escalation study assessing the safety of IMO-2125 in hepatitis C patients; results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) [NA]
A completed clinical trial compares education alone to education plus intervention for diagnosing HIV and hepatitis C virus coinfection.
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort
A real-world Spanish cohort study reports on the effectiveness, safety, and clinical outcomes of elbasvir/grazoprevir for hepatitis C.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Adult-to-Adult Living Donor Transplant Cohort Study
The Clinical Trials entry indicates that the Adult-to-Adult Living Donor Transplant Cohort Study has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study) [Phase 3]
Phase 3 study evaluating the efficacy and safety of narlaprevir boosted with ritonavir in treatment-naïve and pegylated interferon/ribavirin…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation [Phase 2]
Phase 2 study evaluating the fixed-dose combination sofosbuvir/velpatasvir (Epclusa) in adults with hepatitis C undergoing liver transplanta…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic [NA]
Completed clinical trial evaluating a tool to improve treatment adherence and outcomes for hepatitis C at Grady Liver Clinic.
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection
This is a completed use-results surveillance study of Harvoni (ledipasvir/sofosbuvir) in Japanese patients with chronic genotype 1 Hepatitis…
-
CLINICAL_TRIALS research · 2019-02-05Clinical Trial Update: Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs
This clinical trial update investigates whether metabolic changes and vitamin D status influence virological response in patients with Hepat…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents
The completed trial update reports cognitive changes observed in hepatitis C patients after successful eradication of the virus with direct-…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Hepatitis C Infection in World Trade Center Responders
Completed clinical trial update evaluating Hepatitis C infection in World Trade Center responders.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study
The C Tracker Hepatitis C patient-reported outcomes survey study led by Boston Children's Hospital has been terminated.